| Date Filed | Type | Description |
| 01/11/2019 |
SC 13G/A
| ProQuest Investments IV, L.P. reports a 4.9% stake in Urogen Pharma Ltd. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| ProQuest Investments IV, L.P. reports a 7.1% stake in Urogen Pharma Ltd. |
| 11/29/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 31,491 shares
@ $41.12, valued at
$1.3M
Sold 177,807 shares
@ $40.51, valued at
$7.2M
|
|
| 07/20/2017 |
3
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 3 on UroGen Pharma Ltd. |
| 07/20/2017 |
SC 13G
| ProQuest Investments IV, L.P. reports a 11.5% stake in Urogen Pharma Ltd. |
| 05/15/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 05/15/2017 |
SC 13D/A
| ProQuest Investments IV, L.P. reports a 1.4% stake in Eagle Pharmaceuticals, Inc. |
| 04/27/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 04/27/2017 |
SC 13D/A
| ProQuest Investments IV, L.P. reports a 23.9% stake in Eagle Pharmaceuticals, Inc. |
| 04/03/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 03/29/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 03/23/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 03/20/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 01/06/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 01/06/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/14/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 11/09/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 11/04/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 10/04/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 09/30/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 09/23/2016 |
SC 13D/A
| ProQuest Investments IV, L.P. reports a 29.2% stake in Eagle Pharmaceuticals, Inc. |
| 09/08/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 08/25/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 08/19/2016 |
SC 13D/A
| ProQuest Investments IV, L.P. reports a 30.5% stake in Eagle Pharmaceuticals, Inc. |
| 08/17/2016 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 06/30/2016 |
4
| ProQuest Financial LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC. |
| 05/24/2016 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 4,770,828 shares
@ $0
Disposed of 9,360 shares
@ $0 |
|
| 05/16/2016 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 4,000 shares
@ $40, valued at
$160k
Sold 13,980 shares
@ $40.92, valued at
$572.1k
|
|
| 01/29/2016 |
4
| Moorin Jay (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Bought 393,700 shares
@ $6.35, valued at
$2.5M
|
|
| 07/02/2015 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 2,970 shares
@ $0 |
|
| 05/13/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 22,607 shares
@ $22.26, valued at
$503.2k
Sold 155,000 shares
@ $21.5, valued at
$3.3M
|
|
| 05/07/2015 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 9,903 shares
@ $0 |
|
| 04/24/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 25,249 shares
@ $26.56, valued at
$670.6k
Sold 10,000 shares
@ $26.64, valued at
$266.4k
Sold 22,643 shares
@ $27.35, valued at
$619.3k
Sold 25,000 shares
@ $26.64, valued at
$666k
|
|
|